Oncostatin M induces functional and structural impairment of blood-brain barriers comprised of rat brain capillary endothelial cells

Neuroscience Letters

Volumn 441, Issue 2, 2008, Pages 163-166

  Takata, Fuyuko ^a,b   Sumi, Noriko ^a   Nishioku, Tsuyoshi ^a   Harada, Eriko ^a   Wakigawa, Tomoya ^a   Shuto, Hideki ^a   Yamauchi, Atsushi ^a   Kataoka, Yasufumi ^a,b  

^a FUKUOKA UNIVERSITY   (Japan)

^b PharmaCo Cell Co Ltd   (Japan)

Author keywords

Blood brain barrier; Claudin 5; Oncostatin M; Rat brain endothelial cell; Tight junction; ZO 1

Indexed keywords

CLAUDIN 5; CYTOKINE ANTIBODY; INTERLEUKIN 6; ONCOSTATIN M; ONCOSTATIN M ANTIBODY; PROTEIN ZO1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CAPILLARY ENDOTHELIUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MICROGLIA; MONOCYTE; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIBODIES; BLOOD-BRAIN BARRIER; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; GROWTH INHIBITORS; MEMBRANE PROTEINS; MICE; ONCOSTATIN M; RATS; RATS, WISTAR; TIME FACTORS;

EID: 46749116318     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.06.030     Document Type: Article

References (37)

1. Abbott N.J., Ronnback L., and Hannson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7 (2006) 41-53
2. Annunziata P., Cioni C., Santonini R., and Paccagnini E. Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium. J. Neuroimmunol. 131 (2002) 41-49
3. Brooks T.A., Ocheltree S.M., Seelbach M.J., Charles R.A., Nametz N., Egleton R.D., and Davis T.P. Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res. 1120 (2006) 172-182
4. Bugno M., Witek B., Bereta J., Bereta M., Edwards D.R., and Kordula T. Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett. 448 (1999) 9-14
5. Burger D.M., Boucher C.A., Meenhorst P.L., Kraayeveld C.L., Portegies P., Mulder J.W., Hoetelmans R.M., and Beijnen J.H. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier. Antivir. Ther. 2 (1997) 113-117
6. Chen S.H., and Benveniste E.N. Oncostatin M: a pleiotropic cytokine in the central nervous system. Cytokine Growth Factor Rev. 15 (2004) 379-391
7. Dallasta L.M., Pisarov L.A., Esplen J.E., Werley J.V., Moses A.V., Nelson J.A., and Achim C.L. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155 (1999) 1915-1927
8. Deli M.A., Abraham C.S., Kataoka Y., and Niwa M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology and pharmacology. Cell. Mol. Neurobiol. 25 (2005) 59-127
9. Deli M.A., Joó F., Krizbai I., Lengyel I., Nunzi G.M., and Wolff J.-R. Calcium/calmodulin stimulated protein kinase II is present in primary cultures of cerebral endothelial cells. J. Neurochem. 60 (1993) 1960-1963
10. De Vries H.E., Blom-Roosemalen M.C., Van Oosten M., De Boer A.G., Van Berkel T.J., Breimer D.D., and Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64 (1996) 37-43
11. Dohgu S., Takata F., Yamauchi A., Nakagawa S., Egawa T., Naito M., Tsuruo T., Sawada Y., Niwa M., and Kataoka Y. Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res. 1038 (2005) 208-215
12. Ensoli F., Fiorelli V., De Cristofaro M., Santini D., Muratori, Novi A., Vannelli B., Thiele C.J., Luzi G., and Aiuti F. Inflammatory cytokines and HIV-1-associated neurodegeneration: oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons. J. Immunol. 162 (1999) 6268-6277
13. Ensoli F., Fiorelli V., Lugaresi A., Farina D., De Cristofaro M., Collacchi B., Muratori D.S., Scala E., Di Gioacchino M., Paganelli R., and Aiuti F. Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. Mult. Scler. 8 (2002) 284-288
14. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Müller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
15. Hurst R.D., and Fritz I.B. Properties of an immortalised vascular endothelial/glioma cell coculture model of the blood-brain barrier. J. Cell. Physiol. 167 (1996) 81-88
16. Kevil C.G., Oshima T., Alexander B., Coe L.L., and Alexander J.S. H(2)O(2)-mediated permeability: role of MAPK and occluding. Am. J. Physiol. Cell Physiol. 279 (2000) C21-30
17. Kevil C.G., Oshima T., and Alexander J.S. The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. Endothelium 8 (2001) 107-116
18. Kordula T., Rydel R.E., Brigham E.F., Horn F., Heinrich P.C., and Travis J. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. J. Biol. Chem. 273 (1998) 4112-4118
19. Lou J., Chofflon M., Juillard C., Donati Y., Mili N., Siegrist C.A., and Grau G.E. Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity. Neuroreport 8 (1997) 629-633
20. Mayhan W.G. Regulation of blood-brain barrier permeability. Microcirculation 8 (2001) 89-104
21. Nakagawa S., Deli M.A., Nakao S., Honda M., Hayashi K., Nakaoke R., Kataoka Y., and Niwa M. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell. Mol. Neurobiol. 27 (2007) 687-694
22. Pardridge W.M. Drug and gene targeting to the brain with molecular Trojan horses. Nat. Rev. Drug Discov. 1 (2002) 131-139
23. Perriere N., Demeuse P., Garcia E., Regina A., Debray M., Andreux J.P., Couvreur P., Schermann J.M., Temsamani J., Couraud P.O., Deli M.A., and Roux F. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier specific properties. J. Neurochem. 93 (2005) 279-289
24. Repovic P., and Benveniste E.N. Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J. Neurosci. 22 (2002) 5334-5343
25. Repovic P., Mi K., and Benveniste E.N. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1 beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Glia 42 (2003) 433-446
26. Ruchoux M.M., Brulin P., Brillault J., Dehouck M.P., Cecchelli R., and Bataillard M. Lessons from CADASIL. Ann. N. Y. Acad. Sci. 977 (2002) 224-231
27. Rummel C., Voss T., Matsumura K., Korte S., Gerstberger R., Roth J., and Hübschle T. Nuclear STAT3 translocation in guinea pig and rat brain endothelium during systemic challenge with lipopolysaccharide and interleukin-6. J. Comp. Neurol. 491 (2005) 1-14
28. Ruprecht K., Kuhlmann T., Seif F., Hummel V., Kruse N., Brück W., and Rieckmann P. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J. Neuropathol. Exp. Neurol. 60 (2001) 1087-1098
29. Takata F., Dohgu S., Yamauchi A., Sumi N., Nakagawa S., Naito M., Tsuruo T., Shuto H., and Kataoka Y. Inhibition of transforming growth factor-beta production in brain pericytes contributes to cyclosporin A-induced dysfunction of the blood-brain barrier. Cell. Mol. Neurobiol. 27 (2007) 317-328
30. Temesvari P., Abraham C.S., Speer C.P., Kovacs J., and Megyeri P. Escherichia coli O111 B4 lipopolysaccharide given intracisternally induces blood-brain barrier opening during experimental neonatal meningitis in piglets. Pediatr. Res. 34 (1993) 182-186
31. Van Wagoner N.J., Choi C., Repovic P., and Benveniste E.N. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J. Neurochem. 75 (2000) 563-575
32. Vecchiet J., Dalessandro M., Falasca K., Di Iorio A., Travasi F., Zingariello P., Schiavone C., Ensoli F., Pizzigallo E., and Paganelli R. Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. J. Acquir. Immune Defic. Synd. 32 (2003) 464-465
33. Veszelka S., Urbanyi Z., Pazmany T., Nemeth L., Obal I., Dung N.T.K., Abraham C.S., Szabo G., and Deli M.A. Human serum amyloid P component attenuates the bacterial lipopolysaccharide-induced increase in blood-brain barrier permeability in mice. Neurosci. Lett. 352 (2003) 57-60
34. Veszelka S., Pásztói M., Farkas A.E., Krizbai I., Ngo T.K., Niwa M., Abrahám C.S., and Deli M.A. Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages. Neurochem. Int. 50 (2007) 219-228
35. Xaio H., Banks W.A., Niehoff M.L., and Morley J.E. Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res. 896 (2001) 36-42
36. Yanagisawa M., Nakashima K., and Taga T. STAT3-mediated astrocyte differentiation from mouse fetal neuroepithelial cells by mouse oncostatin M. Neurosci. Lett. 269 (1999) 169-172
37. Zarling J.M., Shoyab M., Marquardt H., Hanson M.B., Lioubin M.N., and Todaro G.J. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 9739-9743